LUNG CANCER
Clinical trials for LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new LUNG CANCER trials appear
Sign up with your email to follow new studies for LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Lung cancer brain metastasis study halted after just 3 patients
Disease control TerminatedThis study tested whether adding the drug pembrolizumab to chemotherapy could help people with non-small cell lung cancer that has spread to the brain but is not causing symptoms. The goal was to see if the combination could control the cancer in the brain and improve survival. H…
Matched conditions: LUNG CANCER
Phase: PHASE2 • Sponsor: John L. Villano, MD, PhD • Aim: Disease control
Last updated May 26, 2026 06:02 UTC
-
New drug PHN-010 tested in patients with advanced cancers
Disease control TerminatedThis early-phase study tested a new drug called PHN-010, which delivers a powerful toxin directly to cancer cells. It involved 26 adults with advanced lung, colon, endometrial, ovarian, or cervical cancers that had already been treated. The main goals were to check safety and fin…
Matched conditions: LUNG CANCER
Phase: PHASE1 • Sponsor: Pheon Therapeutics • Aim: Disease control
Last updated May 26, 2026 06:01 UTC
-
Promising lung cancer radiation study halted early
Disease control TerminatedThis study looked at using MRI scans to guide radiation therapy for central lung tumors, which are close to important organs like the heart and windpipe. The goal was to see if this approach is safe and works better than standard CT-guided radiation. Only 3 people took part befor…
Matched conditions: LUNG CANCER
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 06:00 UTC
-
Exercise as medicine: new study targets advanced lung cancer
Disease control TerminatedThis study looked at whether a structured exercise program could improve survival, function, and quality of life for people with advanced lung cancer. It included adults with stage III or metastatic non-small cell lung cancer who were already on maintenance immunotherapy. The stu…
Matched conditions: LUNG CANCER
Phase: NA • Sponsor: Indiana University • Aim: Disease control
Last updated May 26, 2026 05:50 UTC
-
Experimental lung cancer drug shows promise but trial halted early
Disease control TerminatedThis early-stage study tested a new drug, BG-60366, designed to break down a faulty protein (mutant EGFR) that drives growth in some lung cancers. The trial aimed to find a safe dose and see if the drug could shrink tumors in people with advanced non-small cell lung cancer that h…
Matched conditions: LUNG CANCER
Phase: PHASE1 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated May 26, 2026 05:46 UTC
-
Experimental cell therapy tested for advanced lung cancer
Disease control TerminatedThis study tested a personalized treatment called GT201, made from a patient's own immune cells (tumor-infiltrating lymphocytes), for advanced lung cancer. The goal was to see if it was safe and could shrink tumors. Only 2 people took part, and the study was stopped early, so res…
Matched conditions: LUNG CANCER
Phase: NA • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
Lung cancer combo study halted early after only 4 patients
Disease control TerminatedThis study tested a combination of the targeted drug osimertinib and chemotherapy as a first treatment for people with advanced non-small cell lung cancer that has uncommon EGFR mutations. The goal was to see if the combo could shrink tumors and delay cancer growth. However, the …
Matched conditions: LUNG CANCER
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
Scientists hunt for genetic signs that predict lung Cancer's next move
Knowledge-focused TerminatedThis study aimed to find genetic changes in lung tissue and blood that could help predict how squamous cell lung cancer progresses. Researchers planned to collect samples from 200 people having a lung procedure. The study was stopped early and enrolled only 22 participants, so re…
Matched conditions: LUNG CANCER
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 26, 2026 05:42 UTC